Actively Recruiting
Vision Therapy Versus Prism Treatment in Small-angle Acute Acquired Concomitant Esotropia
Led by Eye & ENT Hospital of Fudan University · Updated on 2025-12-09
100
Participants Needed
1
Research Sites
117 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This is a single-center, randomized controlled clinical trial to compare the effectiveness of vision therapy and prism wearing for the treatment of small-angle acute acquired concomitant esotropia.
CONDITIONS
Official Title
Vision Therapy Versus Prism Treatment in Small-angle Acute Acquired Concomitant Esotropia
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Aged 10-40 years (including 10 years and 40 years)
- Best-corrected visual acuity no worse than 20/20 for both eyes
- Deviation angle less than 15 prism diopters (including 15 prism diopters)
You will not qualify if you...
- Organic eye diseases
- Lesions of the brain
- Receiving esotropia therapy (including surgery and prism treatment)
- Deviation angle reducing more than 10 prism diopters after refractive correction
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Eye & ENT Hospital of Fudan University
Shanghai, China
Actively Recruiting
Research Team
W
Wen Wen, MD, PhD
CONTACT
S
Shuyang Guo, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here